RETEVMO

Identification of Retevmo

No description

Google image searchProduct monograph

Active ingredient

selpercatinib, 40 MG

DIN: 02516918

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: LOXO ONCOLOGY INC

Date: 21-JAN-2022

ATC:

Search on Google